Glimpse Group Inc

For the period ended Mar 31, 2024. Filed May 15, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 15, 2024

BTLN$3.67+4.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity

FOR THE THREE MONTHS ENDED MARCH 31, 2024

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of January 1, 2024	16,722,146	$16,723	$72,283,210	$(57,502,788)	$14,797,145
Common stock issued to vendors for compensation	5,626	5	15,185	-	15,190
Common stock issued to satisfy contingent acquisition obligations	750,000	750	846,752	-	847,502
Common stock and stock option based compensation expense	329,803	330	468,011	-	468,341
Common stock and stock option based board of directors expense	332,642	333	501,616	-	501,949
Net loss	-	-	-	(1,542,256)	(1,542,256)
Balance as of March 31, 2024	18,140,217	$18,141	$74,114,774	$(59,045,044)	$15,087,871

FOR THE NINE MONTHS ENDED MARCH 31, 2024

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of July 1, 2023	14,701,929	$14,702	$67,854,108	$(56,644,978)	$11,223,832
Common stock issued in Securities Purchase Agreement, net	1,885,715	1,886	2,966,615	-	2,968,501
Common stock issued to vendors for compensation	34,197	34	88,438	-	88,472
Common stock issued for exercise of options	8,819	9	(9)	-	-
Common stock issued to satisfy contingent acquisition obligations	785,714	786	973,861	-	974,647
Common stock and stock option based compensation expense	391,201	391	1,586,870	-	1,587,261
Common stock and stock option based board of directors expense	332,642	333	644,891	-	645,224
Net loss	-	-	-	(2,400,066)	(2,400,066)
Balance as of March 31, 2024	18,140,217	$18,141	$74,114,774	$(59,045,044)	$15,087,871

FOR THE THREE MONTHS ENDED MARCH 31, 2023

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of January 1, 2023	13,966,007	$13,968	$63,069,423	$(32,156,057)	$30,927,334
Common stock issued to vendors for compensation	1,800	2	5,236	-	5,238
Common stock issued for exercise of options	15,315	15	21,180	-	21,195
Common stock issued for contingent acquisition obligation	326,684	326	1,358,678	-	1,359,004
Common stock and stock option based compensation expense	30,326	30	847,372	-	847,402
Stock option-based board of directors expense	-	-	85,752	-	85,752
Net loss	-	-	-	(5,222,598)	(5,222,598)
Balance as of March 31, 2023	14,340,132	$14,341	$65,387,641	$(37,378,655)	$28,023,327

FOR THE NINE MONTHS ENDED MARCH 31, 2023

Common Stock · Additional · Accumulated
	Shares	Amount	Paid-In Capital	Deficit	Total
Balance as of July 1, 2022	12,747,624	$12,749	$56,885,815	$(28,081,695)	$28,816,869
Common stock issued for acquisition	714,286	714	2,845,430	-	2,846,144
Common stock issued for satisfaction of prior year acquisition liability	214,288	214	733,822	-	734,036
Common stock issued for purchase of intangible asset - technology	71,430	72	326,364	-	326,436
Common stock issued to vendors for compensation	1,800	2	5,236	-	5,238
Common stock issued for exercise of options	41,996	42	66,069	-	66,111
Common stock issued for contingent acquisition obligation	469,541	469	1,874,605	-	1,875,074
Common stock and stock option based compensation expense	79,167	79	2,270,981	-	2,271,060
Stock option-based board of directors expense	-	-	379,319	-	379,319
Net loss	-	-	-	(9,296,960)	(9,296,960)
Balance as of March 31, 2023	14,340,132	$14,341	$65,387,641	$(37,378,655)	$28,023,327

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.